C.H. de Valenciennes
Welcome,         Profile    Billing    Logout  
 0 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ETTAHAR, Nicolas KADER
SPLEEN, NCT04199403: Assessment of Complication Risk Factors in a French National Cohort of Asplenic Patients

Recruiting
N/A
6000
Europe
Poitiers University Hospital, Pr Pierre BUFFET Institut National de la Transfusion Sanguine, Dr Edouard TUAILLON Département Bactériologie-Virologie/INSERM U1058 CHU de Montpellier
Asplenia
01/40
01/40
SEVASAR, NCT04863547: Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection

Recruiting
N/A
2200
Europe, RoW
Data collection
ANRS, Emerging Infectious Diseases
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
04/21
05/21
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ETTAHAR, Nicolas KADER
SPLEEN, NCT04199403: Assessment of Complication Risk Factors in a French National Cohort of Asplenic Patients

Recruiting
N/A
6000
Europe
Poitiers University Hospital, Pr Pierre BUFFET Institut National de la Transfusion Sanguine, Dr Edouard TUAILLON Département Bactériologie-Virologie/INSERM U1058 CHU de Montpellier
Asplenia
01/40
01/40
SEVASAR, NCT04863547: Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection

Recruiting
N/A
2200
Europe, RoW
Data collection
ANRS, Emerging Infectious Diseases
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
04/21
05/21

Download Options